Results 131 to 140 of about 1,491 (172)

Risk of Postoperative Hypermagnesemia in Cardiopulmonary Bypass-Assisted Cardiovascular Surgery. [PDF]

Kidney360
Ghaddar M, Hatab T, El-Kaakour A, Tamim H, Makki M, El-Halabi T, Rifaii K, Sfeir P, Hoteit M, Koubar SH.   +9 more
europepmc   +1 more source

Single-centre, single-blind, randomized, active-controlled phase-3 non-inferiority study to investigate the safety and efficacy of the cardioplegic solution Cardioplexol™. [PDF]

Front Cardiovasc Med
Tevaearai Stahel HT, Weiss G, Landowski P, Folkmann S, Harrer M, Voet B, Grabenwöger M.   +6 more
europepmc   +1 more source

Comparison of myocardial cooling effects between antegrade and retrograde cardioplegia: a retrospective study using thermography. [PDF]

J Cardiothorac Surg
Nishimura Y, Kuwahara G, Wada H.
europepmc   +1 more source

Del Nido cardioplegia in adult cardiac surgery: A narrative review. [PDF]

Perfusion
Najmuddin II, Sainath P, Pillai VK.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Preparation of cardioplegic solutions

American Journal of Health-System Pharmacy, 1979
The manufacturing methods and quality control procedures for two cardioplegic solutions are described. Procedures for preparing individual bottles or batches of two cardioplegic solutions (one with and one without albumin) and a carbonate-bicarbonate buffer solution are described.
John D Bowman, Stanley B Digerness, Vincent R Conti   +2 more
exaly   +3 more sources

Nifedipine stability in cardioplegic solution

American Journal of Health-System Pharmacy, 1984
The stability of nifedipine in cardioplegic solution was studied. Cardioplegic solutions containing nifedipine at 275 and 500 micrograms/liter were stored in plastic bags covered in brown plastic wrappers (1) under normal room light at 25 degrees C and (2) in a dark refrigerator at 4 degrees C. Samples were removed periodically for 48 hours.
M B, Bottorff, D A, Graves, R G, McAllister, R L, Batenhorst, T S, Foster   +4 more
openaire   +2 more sources

Retrieval of crystalloid cardioplegic solutions

The Annals of Thoracic Surgery, 1996
We describe a very simple method to minimize the systemic hemodilution associated with crystalloid cardioplegic solutions, either in an antegrade or retrograde fashion.
P M, Eucher, M, Buche, S, Broka, J C, Schoevaerdts   +3 more
openaire   +2 more sources

Vascular effects of potassium cardioplegic solutions

General Pharmacology: The Vascular System, 1983
Experiments have been performed on isolated human umbilical and sheep coronary arteries, studying the effects of increasing potassium concentration in steps from 10 to 160 mM. Comparative studies were also done on rat-heart papillary-muscle preparations. The results revealed a dose-dependent increase in smooth muscle tone of the blood vessels.
J S, Juggi, O, Thulesius, A O, Elkhawad, H J, Shuhaiber, A M, Yousof   +4 more
openaire   +2 more sources

Oxygenation of cardioplegic solutions: A note of caution

The Annals of Thoracic Surgery, 1991
The merits of oxygenated crystalloid cardioplegic solutions have been well established in experimental animals. The positive effects of oxygenation of Plasmalyte B (Sabax Ltd) and St. Thomas Hospital solution (Plegisol) were achieved by gassing with 95% O2/5% CO2 and 100% O2, respectively.
A, Lochner, L, Lloyd, W, Brits, A, Coetzee   +3 more
openaire   +2 more sources

The Optimal Potassium Concentration in Cardioplegic Solutions

The Annals of Thoracic Surgery, 1981
High-energy phosphates provide a sensitive index of myocardial preservation. This experiment was designed to use this index in order to assess the efficacy of various potassium concentrations in a crystalloid cardioplegic solution in protecting the myocardium during hypothermic ischemic arrest.
J H, Rousou, R M, Engelman, W A, Dobbs, S, Lemeshow   +3 more
openaire   +2 more sources